Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter KRT20 Antikörper

Der Kaninchen Monoklonal anti-KRT20 Antikörper wird verwendet zum Nachweis von KRT20 in Proben von Human, Maus und Ratte. Er wurde validiert für WB, IHC, IF, ICC, IP und FACS.
Produktnummer ABIN7881391
644,88 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Rekombinanter KRT20 Antikörper (ABIN7881391)

Target

Alle KRT20 Antikörper anzeigen
KRT20 (Keratin 20 (KRT20))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 193
  • 43
  • 34
  • 7
  • 6
  • 2
  • 2
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 114
  • 83
  • 4
  • 1
Kaninchen

Klonalität

  • 136
  • 65
  • 1
Monoklonal

Konjugat

  • 123
  • 18
  • 8
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KRT20 Antikörper ist unkonjugiert

Applikation

  • 157
  • 116
  • 42
  • 39
  • 36
  • 34
  • 29
  • 28
  • 26
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC), Immunoprecipitation (IP), Flow Cytometry (FACS)

Klon

CDI-11
  • Verwendungszweck

    KRT20 Antibody / Cytokeratin 20 / CK20

    Aufreinigung

    Affinity chromatography

    Immunogen

    A synthesized peptide derived from human Cytokeratin 20 was used as the immunogen for the KRT20 antibody.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal dilution of the KRT20 antibody should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store the KRT20 antibody at -20oC.
  • Target

    KRT20 (Keratin 20 (KRT20))

    Andere Bezeichnung

    KRT20

    Hintergrund

    KRT20 antibody detects Cytokeratin 20, an intermediate filament protein encoded by the KRT20 gene on chromosome 17q21.2. Cytokeratin 20 (CK20) is a member of the type I keratin family and is expressed primarily in epithelial cells of the gastrointestinal tract, urothelium, and Merkel cells of the skin. CK20 provides structural stability to epithelial cells and serves as a diagnostic marker in pathology for identifying tissue origin and differentiation status in epithelial tumors. Its expression pattern is especially valuable for distinguishing colorectal, gastric, and bladder carcinomas.

    Structurally, CK20 is a 46 kDa cytoskeletal protein composed of a central alpha-helical rod domain flanked by non-helical head and tail domains, allowing filament assembly with type II keratins such as KRT8. CK20 belongs to the cytokeratin family of intermediate filaments that provide mechanical resilience and maintain epithelial integrity. Co-localization studies show CK20 distributed in the cytoplasm and perinuclear region, forming filamentous networks characteristic of simple epithelia.

    Functionally, CK20 supports epithelial cell shape, polarity, and resistance to mechanical stress. It interacts with desmosomal and hemidesmosomal components to anchor the cytoskeleton to cell junctions, maintaining tissue architecture. CK20 also participates in cellular differentiation programs, serving as a marker of terminal differentiation in gastrointestinal epithelia and Merkel cells. In the urothelium, CK20 expression increases during tissue repair and regeneration.

    Clinically, CK20 serves as an important immunohistochemical marker in cancer diagnostics. It is strongly expressed in colorectal adenocarcinomas, transitional cell carcinomas of the bladder, and some gastric cancers, while absent in most lung, breast, and prostate carcinomas. Combined with CK7 expression patterns, CK20 staining aids in identifying metastatic tumor origin. Dysregulation of KRT20 gene expression has been linked to epithelial barrier dysfunction and tumor progression. Pathway involvement includes cytoskeletal organization, epithelial differentiation, and stress response signaling.

    Immunohistochemical staining using KRT20 antibody reveals strong cytoplasmic filamentous localization in gastrointestinal and urothelial epithelia. The KRT20 antibody from NSJ Bioreagents is an ideal reagent for epithelial marker studies, cancer diagnostics, and cytoskeletal research.

    UniProt

    P35900
Sie sind hier:
Chat with us!